Active Ingredient (In Each Tablet)
Sennosides 8.6 mg
The following Structured Product Label (SPL) was submitted to the FDA by Rising Pharma Holdings, Inc. for the product Senaklear (NDC 57237-371). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Sennosides 8.6 mg
Laxative
Do not use
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
age | starting dosage | maximum dosage |
adults and children 12 years of age and over | 2 tablets once a day | 4 tablets twice a day |
children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
children 2 to under 6 years | ½ tablet once a day | 1 tablet twice a day |
children under 2 years | ask a doctor | ask a doctor |
Colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate, hypromellose 15, hypromellose 5, magnesium stearate, microcrystalline cellulose, paraffin liquid, sodium lauryl sulphate, stearic acid
call 1-844-474-7464
NDC 57237-371-99
Senaklear™
Sennoside Tablets, USP 8.6 mg
Regular Strength
Natural Vegetable Laxative Ingredient
1000 Tablets
* Please review the disclaimer below.